SCHEMBL1633304

SCHEMBL1633304

O=S(=O)(c1cccc(Nc2ncc3c(Cl)ccc(OC4CNC4)c3n2)c1)N1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 1/20 0.45
CDK1 P06493 1/20 0.45
CCNB1 P14635 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
CDK7 P50613 1/20 0.45
CDK9 P50750 1/20 0.45
CCNH P51946 1/20 0.45
POLB P06746 1/20 0.45
PKM P14618 1/20 0.45
KCNA5 P22460 2/20 0.43
ERBB2 P04626 4/20 0.43
PTK6 Q13882 3/20 0.43
BRD4 O60885 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
ATM Q13315 1/20 0.43
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
ALDH1A1 P00352 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13498315 0.86 JAK2 (0.51) CCNT1CCNA2CDK2CDK9BRD4
SCHEMBL1633103 0.83 JAK2 (0.44) CCNT1CDK1CCNB1CCNA2CDK2
SCHEMBL1634818 0.82 SYK (0.47) CDK1CCNB1CDK2CDK7TDP1
SCHEMBL1632734 0.82 IGF1R (0.46) CCNT1CCNA2CDK2CDK9
SCHEMBL1633570 0.81 CDK2 (0.50) CDK1CCNB1CCNA2CDK2CDK9
SCHEMBL1633493 0.80 JAK2 (0.58) CCNT1CDK1CCNB1CCNA2CDK2
SCHEMBL1632896 0.80 MAPK9 (0.49) CDK1CCNB1CDK2
SCHEMBL1634301 0.79 LRRK2 (0.55) LRRK2
SCHEMBL1633182 0.78 JAK2 (0.54) CCNT1CCNA2CDK2CDK9BRD4
SCHEMBL12724051 0.75 JAK2 (0.48) CCNT1CDK1CCNB1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed